Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and laparoscopic device used to fix hernia meshes placed inside the body under the LiquiBand Fix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal brand. Advanced Medical Solutions Group plc was incorporated in 1991 and is headquartered in Winsford, the United Kingdom.

Advanced Medical Solutions Group plc

Activ Surgical is involved in the development of surgical technologies and tools. Self-described as innovative, it focuses on enhancing surgical procedures through its technological offerings.

Activ Surgical

Advanced Medical Solutions Group plc is a specialist in tissue-healing technologies, employing over 1,500 people across 17 locations.

Metric
Company Name	Advanced Medical Solutions Group plc	Activ Surgical
Symbol	AMS
MSH ID	COM:ADMEDSOL	COM:ACTIVSURGICAL
Market	STOCKS	PRIVATE
Sector	Healthcare	Healthcare & Health Services
Industry	Medical - Instruments & Supplies	Medical Devices
Country	GB	US
Stage
Employee Count	850
Website	admedsol.com	activsurgical.com
LinkedIn
Founders

Metric
Market Cap	6.37M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	160.82M
Revenue (LTM)
Revenue (NTM)
Gross Profit	81.20M
EBITDA	39.11M
Operating Income	25.36M
Net Income	20.25M
EPS	0.09
Diluted EPS	0.09
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.54
Operating Profit Margin	0.14
EBITDA Margin	0.24
Net Profit Margin	0.13
Return on Equity	0.07
Return on Assets	0.05
Return on Capital Employed	0.07

COM:ADMEDSOL

Advanced Medical Solutions Group plc

Last Close

209.50

25/11 09:22

Market Cap

5.00M

Beta: -

Volume Today

97.99K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	21.80
P/B Ratio	1.88
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	4.31
EV Multiple	25.16

Metric
Days Sales Outstanding
Days Payables Outstanding	148.19
Days Inventory Outstanding	235.67
Operating Cycle	316.40
Cash Conversion Cycle	181.41
Asset Turnover	0.44

Metric
Operating Cash Flow	18.42M
Free Cash Flow	5.87M
Cash Flow to Debt	12.42
Operating Cash Flow/Sales	0.12
Free Cash Flow Yield	0.04

Metric
Cash & Equivalents	76.66M
Accounts Receivable	-3.20M
Inventory	45.93M
Goodwill
Debt to Capitalization	0.25
Debt to Assets	0.03
Current Ratio	5.82
Quick Ratio	6.80

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.02
R&D to Revenue
SG&A to Revenue	0.38